ScholarIQanswers from OpenAlex & ORCID
Kristian Reich
ResearcherPublications, citations & collaboration network
Kristian Reich is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Kristian Reich have?
ScholarIQindexed works
Kristian Reich has 738 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Kristian Reich have?
ScholarIQcitation count
Kristian Reich has 43,296 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Kristian Reich?
ScholarIQh-index
Kristian Reich has an h-index of 105 in OpenAlex.
What is the i10-index of Kristian Reich?
ScholarIQi10-index
Kristian Reich has an i10-index of 395 in OpenAlex.
What is the ORCID of Kristian Reich?
ScholarIQorcid
The ORCID for Kristian Reich is on the source record.
What is the OpenAlex record for Kristian Reich?
ScholarIQopenalex
The OpenAlex for Kristian Reich is on the source record.
What are the most-cited papers on Kristian Reich?
ScholarIQmost cited works
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
Kim Papp, Richard G. Langley, Mark Lebwohl, Gerald G. Krueger, Philippe Szapary, Newman Yeilding, Cynthia Guzzo, Ming-Chun Hsu, Yuhua Wang, Shu Li, Lisa T. Dooley, Kristian Reich
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Kenneth B. Gordon, Andrew Blauvelt, Kim Papp, Richard G. Langley, Thomas A. Luger, Mamitaro Ohtsuki, Kristian Reich, David A. Amato, Susan Ball, Daniel Braun, Gregory S. Cameron, J. Erickson, Robert J. Konrad, Talia M. Muram, Brian J. Nickoloff, Olawale Osuntokun, Roberta J. Secrest, Fangyi Zhao, Lotus Mallbris, Craig L. Leonardi
European S3‐Guidelines on the systemic treatment of psoriasis vulgaris
Delano Pathirana, AD Ormerod, P. Saïag, Catherine Smith, P.I. Spuls, Alexander Nast, Juliet N. Barker, JD Bos, GR Burmester, Sergio Chimenti, Louis Dubertret, Bernadette Eberlein, R. Erdmann, John L. Ferguson, Giampiero Girolomoni, Paolo Gisondi, Alessandro Giunta, C.E.M. Griffiths, Herbert Hönigsmann, Mohammad Enayet Hussain, Ray Jobling, S‐L Karvonen, Lajos Kemény, I. Kopp, C. Leonardi, Mara Maccarone, Alan Menter, Ulrich Mrowietz, Luigi Naldi, Tamar Nijsten, Ortonne Jp, H‐D Orzechowski, Tapio Rantanen, Kristian Reich, Natalie Reytan, Helen L. Richards, HB Thio, Peter van de Kerkhof, Berthold Rzany
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
Kristian Reich, Kim Papp, Andrew Blauvelt, Stephen K. Tyring, Rodney Sinclair, Diamant Thaçi, Kristine Nograles, Anish Mehta, N. Cichanowitz, Qing Li, Kenneth Liu, Carmen La Rosa, Stuart Green, Alexa B. Kimball
Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey
Mark Lebwohl, H. Bachelez, Jonathan Barker, Giampiero Girolomoni, Arthur Kavanaugh, Richard G. Langley, C. Paul, L. Puig, Kristian Reich, P.C.M. van de Kerkhof